Intact Disc1-L100P mice carrying a point mutation DISC1Rgsc1390 in the second exon of the DISC1 gene (genetic model of schizophrenia) differ from the parental C57BL/6NCrl strain by higher content of CD3+ T cells and reduced number of CD19+B cells in the peripheral blood and spleen. Analysis of T cell subpopulations revealed an increase in the number of CD3+CD4+ T helpers in the blood of mutant mice and a decrease in the level of CD3+CD8+ suppressor/cytotoxic T cells and CD3+CD4+CD25+ T-regulatory cells. The distribution pattern of inflammatory (IL-1β, IL-2, IL-6, IL-17, IFNγ, and TNFα) and anti-inflammatory (IL-4, IL-10) cytokines specific for Disc1-L100P mice was revealed in the brain structures involved in the pathogenesis of schizophrenia. A possible implication of immune mechanisms in the development of schizophrenia-like endophenotype of Disc1-L100P mice is discussed.
Similar content being viewed by others
References
Alperina EL. Involvement of the dopaminergic system in the mechanisms of immunomodulation. Uspekhi Fiziol. Nauk. 2014;45(3):45-56. Russian.
Vetlugina TP, Lobacheva OA, Alperina EL, Zhukova EN, Semke AV, Nikitina VB, Cheido MA, Idova GV. Clinical and experimental research of immunomodulatory effect of amisulpride. Vestn. Ross. Akad. Med. Nauk. 2012;67(12):13-17. Russian.
Devoino LV, Idova GV, Alperina EL. Psychoneuroimmunomodulation: Behavior and Immunity. The Role of the “Neurotransmitter Setting of the Brain”. Novosibirsk, 2009. Russian.
Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007;54(3):387-402. doi: https://doi.org/10.1016/j.neuron.2007.04.015
Cui L, Sun W, Yu M, Li N, Guo L, Gu H, Zhou Y. Disruptedin-schizophrenia1 (DISC1) L100P mutation alters synaptic transmission and plasticity in the hippocampus and causes recognition memory deficits. Mol. Brain. 2016;9(1):89. doi: https://doi.org/10.1186/s13041-016-0270-y
Dahoun T, Trossbach SV, Brandon NJ, Korth C, Howes OD. The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review. Transl. Psychiatry. 2017;7(1):e1015. doi: https://doi.org/10.1038/tp.2016.282
Debnath M, Berk M. Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr. Bull. 2014;40(6):1412-1421. doi: https://doi.org/10.1093/schbul/sbu049
Fernandez-Egea E, Vértes PE, Flint SM, Turner L, Mustafa S, Hatton A, Smith KG, Lyons PA, Bullmore ET. Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia. PLoS One. 2016;11(5):e0155631. doi: https://doi.org/10.1371/journal.pone.0155631
Idova GV, Alperina EL, Cheido MA. Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis. Int. Immunopharmacol. 2012;12(4):618-625. doi: https://doi.org/10.1016/j.intimp.2012.02.010
Khandaker GM, Dantzer R, Jones PB. Immunopsychiatry: important facts. Psychol. Med. 2017;47(13):2229-2237. doi: https://doi.org/10.1017/S0033291717000745
Lipina TV, Niwa M, Jaaro-Peled H, Fletcher PJ, Seeman P, Sawa A, Roder JC. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav. 2010;9(7):777-789. doi: https://doi.org/10.1111/j.1601-183X.2010.00615.x
Lipina TV, Roder JC. Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: impact of mouse models. Neurosci. Biobehav. Rev. 2014;45:271-294. doi: https://doi.org/10.1016/j.neubiorev.2014.07.001
Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J. Neurosci. 2013;33(18):7654-7666. doi: https://doi.org/10.1523/JNEUROSCI.0091-13.2013
Müller N. Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations. Schizophr. Bull. 2018;44(5):973-982. doi: https://doi.org/10.1093/schbul/sby024
Vidal PM, Pacheco R. The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia. Front. Pharmacol. 2020;11:394. doi: https://doi.org/10.3389/fphar.2020.00394
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 3, pp. 328-332, March, 2021
Rights and permissions
About this article
Cite this article
Al’perina, E.L., Gevorgyan, M.M., Zhanaeva, S.Y. et al. Peculiarities of the Composition of Peripheral Immune Cells and Cytokine Profile in Brain Structures in Mutant DISC1-L100P Mice. Bull Exp Biol Med 171, 347–351 (2021). https://doi.org/10.1007/s10517-021-05225-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05225-0